Personal information

Verified email domains

aerosol, particle engineering, antibiotic for inhalation, dry powder inhalers
Italy

Biography

Francesca Buttini is currently holding an Associate Professor position at the Food and Drug Department of the University of Parma (IT) where she got the PhD title in 2004 and where now she is leading the unit dedicated to design of pharmaceutical products for inhalation. In 2014, she was appointed as Visiting Lecturer at the Institute of Pharmaceutical Science of King’s College London (UK). In 2016 she has been affiliated as Key Researcher at the Research Center Pharmaceutical Engineering (Austria). She was awarded as best emerging scientist by aerosol UK society in 2017.
She works on the development of innovative pulmonary products such as solutions for nebulisation and metered dose inhalers, but her main research area is the formulation and testing of dry powder inhalers. She is an expert both in particle engineering and in development of carrier-based formulations and several of her works were focused on the construction of antibiotic particles.
Up to date, she has published many original papers, 6 book chapters and 5 patents in the field of drugs and drug delivery systems and in the last years she received more than 25 invitations to lecture at international conferences.
Dr Buttini collaborates with many international institutions and with multiple pharmaceutical companies active in the development of pulmonary medicinal products. Finally, in 2013 Francesca is a founder of PlumeStars, an innovative Startup, dedicated to development of orphan drug products to treat lung and systemic disease by inhalation therapy.

Activities

Employment (1)

University of Parma: Parma, IT

Associate Professor (Food and Drug)
Employment
Source: Self-asserted source
Francesca Buttini

Peer review (13 reviews for 7 publications/grants)

Review activity for ACS nano. (2)
Review activity for Drug delivery and translational research. (1)
Review activity for European journal of pharmaceutical sciences. (2)
Review activity for International journal of pharmaceutics (3)
Review activity for Journal of controlled release. (1)
Review activity for Molecular pharmaceutics. (3)
Review activity for Powder technology. (1)